Literature DB >> 27277867

Integrating neuroimmune systems in the neurobiology of depression.

Eric S Wohleb1, Tina Franklin1, Masaaki Iwata2, Ronald S Duman1.   

Abstract

Data from clinical and preclinical studies indicate that immune dysregulation, specifically of inflammatory processes, is associated with symptoms of major depressive disorder (MDD). In particular, increased levels of circulating pro-inflammatory cytokines and concomitant activation of brain-resident microglia can lead to depressive behavioural symptoms. Repeated exposure to psychological stress has a profound impact on peripheral immune responses and perturbs the function of brain microglia, which may contribute to neurobiological changes underlying MDD. Here, we review these findings and discuss ongoing studies examining neuroimmune mechanisms that influence neuronal activity as well as synaptic plasticity. Interventions targeting immune-related cellular and molecular pathways may benefit subsets of MDD patients with immune dysregulation.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27277867     DOI: 10.1038/nrn.2016.69

Source DB:  PubMed          Journal:  Nat Rev Neurosci        ISSN: 1471-003X            Impact factor:   34.870


  222 in total

1.  Social stress induces glucocorticoid resistance in macrophages.

Authors:  J L Stark; R Avitsur; D A Padgett; K A Campbell; F M Beck; J F Sheridan
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2001-06       Impact factor: 3.619

Review 2.  An inflammatory review of glucocorticoid actions in the CNS.

Authors:  Shawn F Sorrells; Robert M Sapolsky
Journal:  Brain Behav Immun       Date:  2006-12-27       Impact factor: 7.217

3.  Evidence for increased microglial priming and macrophage recruitment in the dorsal anterior cingulate white matter of depressed suicides.

Authors:  Susana G Torres-Platas; Cristiana Cruceanu; Gary Gang Chen; Gustavo Turecki; Naguib Mechawar
Journal:  Brain Behav Immun       Date:  2014-05-20       Impact factor: 7.217

4.  Prior exposure to glucocorticoids sensitizes the neuroinflammatory and peripheral inflammatory responses to E. coli lipopolysaccharide.

Authors:  Matthew G Frank; Zurine D Miguel; Linda R Watkins; Steven F Maier
Journal:  Brain Behav Immun       Date:  2009-07-30       Impact factor: 7.217

Review 5.  Physiology of microglia.

Authors:  Helmut Kettenmann; Uwe-Karsten Hanisch; Mami Noda; Alexei Verkhratsky
Journal:  Physiol Rev       Date:  2011-04       Impact factor: 37.312

6.  Antidepressant therapy and C-reactive protein levels.

Authors:  Sinead M O'Brien; Lucinda V Scott; Timothy G Dinan
Journal:  Br J Psychiatry       Date:  2006-05       Impact factor: 9.319

7.  P2RX7, a gene coding for a purinergic ligand-gated ion channel, is associated with major depressive disorder.

Authors:  Susanne Lucae; Daria Salyakina; Nicholas Barden; Mario Harvey; Bernard Gagné; Michel Labbé; Elisabeth B Binder; Manfred Uhr; Marcelo Paez-Pereda; Inge Sillaber; Marcus Ising; Tanja Brückl; Roselind Lieb; Florian Holsboer; Bertram Müller-Myhsok
Journal:  Hum Mol Genet       Date:  2006-07-05       Impact factor: 6.150

Review 8.  The role of inflammation in depression: from evolutionary imperative to modern treatment target.

Authors:  Andrew H Miller; Charles L Raison
Journal:  Nat Rev Immunol       Date:  2016-01       Impact factor: 53.106

9.  The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine.

Authors:  N Müller; M J Schwarz; S Dehning; A Douhe; A Cerovecki; B Goldstein-Müller; I Spellmann; G Hetzel; K Maino; N Kleindienst; H-J Möller; V Arolt; M Riedel
Journal:  Mol Psychiatry       Date:  2006-02-21       Impact factor: 15.992

10.  Neuroinflammatory Dynamics Underlie Memory Impairments after Repeated Social Defeat.

Authors:  Daniel B McKim; Anzela Niraula; Andrew J Tarr; Eric S Wohleb; John F Sheridan; Jonathan P Godbout
Journal:  J Neurosci       Date:  2016-03-02       Impact factor: 6.167

View more
  179 in total

Review 1.  The cellular and molecular basis of major depressive disorder: towards a unified model for understanding clinical depression.

Authors:  Eleni Pitsillou; Sarah M Bresnehan; Evan A Kagarakis; Stevano J Wijoyo; Julia Liang; Andrew Hung; Tom C Karagiannis
Journal:  Mol Biol Rep       Date:  2019-10-14       Impact factor: 2.316

2.  Epigenetic Aging in Major Depressive Disorder.

Authors:  Laura K M Han; Moji Aghajani; Shaunna L Clark; Robin F Chan; Mohammad W Hattab; Andrey A Shabalin; Min Zhao; Gaurav Kumar; Lin Ying Xie; Rick Jansen; Yuri Milaneschi; Brian Dean; Karolina A Aberg; Edwin J C G van den Oord; Brenda W J H Penninx
Journal:  Am J Psychiatry       Date:  2018-04-16       Impact factor: 18.112

Review 3.  Low Vs. High Alcohol: Central Benefits Vs. Detriments.

Authors:  Yousef Tizabi; Bruk Getachew; Clifford L Ferguson; Antonei B Csoka; Karl M Thompson; Alejandra Gomez-Paz; Jana Ruda-Kucerova; Robert E Taylor
Journal:  Neurotox Res       Date:  2018-01-04       Impact factor: 3.911

Review 4.  Neurobiology of Resilience: Interface Between Mind and Body.

Authors:  Flurin Cathomas; James W Murrough; Eric J Nestler; Ming-Hu Han; Scott J Russo
Journal:  Biol Psychiatry       Date:  2019-04-17       Impact factor: 13.382

5.  Adult neuroplasticity: A new “cure” for major depression?

Authors:  Paul R. Albert
Journal:  J Psychiatry Neurosci       Date:  2019-03-01       Impact factor: 6.186

Review 6.  SARS-CoV-2 and nervous system: From pathogenesis to clinical manifestation.

Authors:  Kiandokht Keyhanian; Raffaella Pizzolato Umeton; Babak Mohit; Vahid Davoudi; Fatemeh Hajighasemi; Mehdi Ghasemi
Journal:  J Neuroimmunol       Date:  2020-11-07       Impact factor: 3.478

7.  Altered B Cell Homeostasis in Patients with Major Depressive Disorder and Normalization of CD5 Surface Expression on Regulatory B Cells in Treatment Responders.

Authors:  Diana Ahmetspahic; Kathrin Schwarte; Oliver Ambrée; Christian Bürger; Vladislava Falcone; Katharina Seiler; Mehrdad Rahbar Kooybaran; Laura Grosse; Fernand Roos; Julia Scheffer; Silke Jörgens; Katja Koelkebeck; Udo Dannlowski; Volker Arolt; Stefanie Scheu; Judith Alferink
Journal:  J Neuroimmune Pharmacol       Date:  2017-09-13       Impact factor: 4.147

Review 8.  Inflammation, Glutamate, and Glia: A Trio of Trouble in Mood Disorders.

Authors:  Ebrahim Haroon; Andrew H Miller; Gerard Sanacora
Journal:  Neuropsychopharmacology       Date:  2016-09-15       Impact factor: 7.853

Review 9.  Treatment resistant depression: A multi-scale, systems biology approach.

Authors:  Huda Akil; Joshua Gordon; Rene Hen; Jonathan Javitch; Helen Mayberg; Bruce McEwen; Michael J Meaney; Eric J Nestler
Journal:  Neurosci Biobehav Rev       Date:  2017-08-30       Impact factor: 8.989

10.  Periaqueductal Gray Glutamatergic Transmission Governs Chronic Stress-Induced Depression.

Authors:  Yu-Cheng Ho; Tzer-Bin Lin; Ming-Chun Hsieh; Cheng-Yuan Lai; Dylan Chou; Yat-Pang Chau; Gin-Den Chen; Hsien-Yu Peng
Journal:  Neuropsychopharmacology       Date:  2017-08-30       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.